The published programme examples explore neurodegeneration and liver toxicity. Neither is presented here as an approved therapy or a clinically validated product.
01 /
NEURODEGENERATION
Parkinson’s disease
CellCodex reports genome-wide screens in human dopamine neurons that indicated a novel pathway now being investigated.
Reference & provenance
CellCodex reports genome-wide screens in human dopamine neurons that indicated a novel pathway now being investigated. The reviewed material does not identify the pathway or establish a named clinical candidate, clinical phase or patient efficacy.
A research programme investigating human hepatocyte models to study and predict drug-induced liver injury. The company describes it as Innovate UK-backed.
Reference & provenance
A research programme investigating human hepatocyte models to study and predict drug-induced liver injury. The company describes it as Innovate UK-backed; the reviewed sources do not establish an award identifier, amount, clinical predictive benchmark or regulatory qualification.
